Literature DB >> 6093268

Chronic mononucleosis syndrome.

R E DuBois, J K Seeley, I Brus, K Sakamoto, M Ballow, S Harada, T A Bechtold, G Pearson, D T Purtilo.   

Abstract

We present data on 14 patients with chronic symptoms of disabling fatigue in association with serologic evidence of active Epstein-Barr virus (EBV) infection. Two thirds were women, and the average age at onset was 29.6 years. Forty-three percent were known to have had previous infectious mononucleosis, but the usual criteria for that diagnosis were not helpful with the present syndrome. Eighty-six percent had serologic evidence of cytomegalovirus (CMV) infection. Profound immunodeficiency was not present, but 71% had partial hypogammaglobulinemia, and minor abnormalities of T cell subsets were noted in six of seven patients studied. Fifty-seven percent achieved temporary serologic and symptomatic remission after an average duration of 33 months. Only one patient has a sustained remission. Comparison is made with other reported chronic, recurrent, and persistent EBV syndromes, and tentative diagnostic criteria for chronic mononucleosis syndrome are presented. Recently available EBV serologic techniques allow for identification of patients who have reactivated EBV infection, and this reactivation may be related to symptoms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093268     DOI: 10.1097/00007611-198411000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  25 in total

1.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

Review 2.  [Definition of "chronic fatigue syndrome" (CFS)].

Authors:  U Heyll; P Wachauf; V Senger; M Diewitz
Journal:  Med Klin (Munich)       Date:  1997-04-15

Review 3.  Uncommon illness from common infections.

Authors:  C L Christian
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

Review 4.  Treatment of patients with chronic fatigue syndrome.

Authors:  N M Gantz; G P Holmes
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

5.  Induction of Epstein-Barr virus early antigens by tumor promoters of the diterpene ester type in Raji cells and specific (receptor) binding as compared to irritant and promoting activities.

Authors:  U Kloz; M Hergenhahn; M Fellhauer; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Chronic Epstein-Barr virus syndrome.

Authors:  J F Jones
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

7.  Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Authors:  W Henle; G Henle; J Andersson; I Ernberg; G Klein; C A Horwitz; G Marklund; L Rymo; C Wellinder; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.

Authors:  N A Miller; H A Carmichael; B D Calder; P O Behan; E J Bell; R A McCartney; F C Hall
Journal:  BMJ       Date:  1991-01-19

Review 9.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Lymphocyte phenotype and function in the chronic fatigue syndrome.

Authors:  S E Straus; S Fritz; J K Dale; B Gould; W Strober
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.